Latest Period
Q1 2026
Security Snapshot
MediWound Ltd. - COMMON STOCK (MDWD) Institutional Ownership
CUSIP: M68830112
13F Institutional Holders and Ownership History from Q4 2022 to Q1 2026
Institutions Reporting
72
Shares (Excl. Options)
6,021,491
Price
$16.11
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COMMON STOCK
- Symbol
- MDWD on Nasdaq
- Shares outstanding
- 12,906,309
- Price per share
- $16.57
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 6,021,491
- Total reported value
- $96,994,248
- % of total 13F portfolios
- 0%
- Share change
- +171,554
- Value change
- +$2,141,204
- Number of holders
- 72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- MDWD - MediWound Ltd. - COMMON STOCK is tracked under CUSIP M68830112.
- 72 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 78 to 72 between Q4 2025 and Q1 2026.
- Reported value moved from $114,744,613 to $96,994,248.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 72 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP M68830112?
CUSIP M68830112 identifies MDWD - MediWound Ltd. - COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP M68830112:
Significant Owners of MediWound Ltd. - COMMON STOCK (MDWD) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ACCESS INDUSTRIES, LLC | 12% | $26,690,490 | 1,481,521 | Access Industries Holdings LLC | 30 Sep 2025 | |||
| Yelin Lapidot Holdings Management Ltd. | 6% | $14,085,491 | 763,069 | Yelin Lapidot Holdings Management Ltd. | 31 Dec 2025 | |||
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.5% | +30% | $12,528,800 | +$2,741,910 | 709,847 | +28% | T. Rowe Price Associates, Inc. | 31 Mar 2026 |
As of 31 Mar 2026, 72 institutional investors reported holding 6,021,491 shares of MediWound Ltd. - COMMON STOCK (MDWD). This represents 47% of the company’s total 12,906,309 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of MediWound Ltd. - COMMON STOCK (MDWD) together control 45% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| INVESTOR AB | 6.8% | 872,093 | 0% | 0.09% | $14,049,418 |
| Yelin Lapidot Holdings Management Ltd. | 5.9% | 762,817 | -0.03% | 2.6% | $12,288,982 |
| Rosalind Advisors, Inc. | 5.8% | 749,054 | 0% | 4.9% | $12,067,260 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.5% | 709,847 | +28% | 0% | $11,437,000 |
| BlackRock, Inc. | 3.5% | 445,834 | -2.2% | 0% | $7,182,386 |
| MEITAV INVESTMENT HOUSE LTD | 2.9% | 371,868 | +0.07% | 0.07% | $5,979,625 |
| SPHERA FUNDS MANAGEMENT LTD. | 2.1% | 273,192 | +19% | 0.76% | $4,401,123 |
| Silverberg Bernstein Capital Management LLC | 1.5% | 200,005 | +8.7% | 1.8% | $3,222,081 |
| Point72 Asset Management, L.P. | 1.4% | 175,479 | 0% | $2,826,967 | |
| UBS Group AG | 1.2% | 159,791 | +10% | 0% | $2,574,233 |
| STATE STREET CORP | 1.1% | 143,770 | +15% | 0% | $2,316,135 |
| ARK Investment Management LLC | 1% | 129,961 | +22% | 0.02% | $2,093,672 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94% | 121,958 | +1.5% | 0% | $1,964,742 |
| NORTHERN TRUST CORP | 0.94% | 121,776 | +1.7% | 0% | $1,961,811 |
| DAFNA Capital Management LLC | 0.73% | 94,405 | -17% | 0.35% | $1,520,865 |
| MORGAN STANLEY | 0.69% | 88,473 | +20% | 0% | $1,425,299 |
| Clal Insurance Enterprises Holdings Ltd | 0.55% | 71,000 | 0% | 0.01% | $1,144,000 |
| Sargent Investment Group, LLC | 0.46% | 59,481 | -0.74% | 0.13% | $958,239 |
| CITADEL ADVISORS LLC | 0.46% | 59,240 | -34% | 0% | $954,356 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.45% | 57,547 | 0% | 0% | $927,082 |
| Summit Financial, LLC | 0.37% | 47,271 | -1.5% | 0.01% | $761,536 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.34% | 44,300 | +273% | 0% | $713,673 |
| LPL Financial LLC | 0.19% | 24,597 | +12% | 0% | $396,258 |
| MGO ONE SEVEN LLC | 0.17% | 22,163 | +0% | 0.01% | $357,046 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.17% | 21,407 | -12% | 0% | $344,867 |
Institutional Holders of MediWound Ltd. - COMMON STOCK (MDWD) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 6,021,491 | $96,994,248 | +$2,141,204 | $16.11 | 72 |
| 2025 Q4 | 6,216,171 | $114,744,613 | +$2,107,375 | $18.46 | 78 |
| 2025 Q3 | 5,778,679 | $104,111,829 | +$23,715,525 | $18.02 | 76 |
| 2025 Q2 | 4,442,023 | $85,989,187 | +$3,071,743 | $19.37 | 68 |
| 2025 Q1 | 4,289,778 | $66,585,796 | -$2,366,819 | $15.52 | 63 |
| 2024 Q4 | 4,433,164 | $78,971,410 | +$4,139,849 | $17.80 | 63 |
| 2024 Q3 | 4,206,185 | $75,981,808 | +$27,892,207 | $18.06 | 62 |
| 2024 Q2 | 2,630,827 | $40,820,795 | +$7,033,940 | $15.52 | 45 |
| 2024 Q1 | 2,187,317 | $31,168,844 | -$4,415,868 | $14.25 | 29 |
| 2023 Q4 | 2,515,545 | $25,600,177 | -$1,480,661 | $10.17 | 21 |
| 2023 Q3 | 1,958,560 | $20,872,009 | -$1,549,963 | $10.64 | 17 |
| 2023 Q2 | 2,053,426 | $21,845,490 | +$703,251 | $10.66 | 19 |
| 2023 Q1 | 1,983,430 | $26,431,471 | +$16,001,516 | $13.32 | 21 |
| 2022 Q4 | 779,371 | $10,500,782 | +$10,500,782 | $13.49 | 17 |